CD36 and acute respiratory distress syndrome: Besides, synthetic amphipathic helical peptides (SAHPs), which also exhibits relative selectivity towards CD36, exert a significant impact on inhibiting acute pulmonary inflammation and dysfunction, and can be regarded as a potential novel approach for treating ALI and pulmonary edema [43].